|
NAP1L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.912100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.435800E-02 |
| Normal-vs-Stage2 |
2.900000E-01 |
| Normal-vs-Stage3 |
2.348200E-01 |
| Normal-vs-Stage4 |
4.400900E-03 |
| Stage1-vs-Stage2 |
6.436600E-01 |
| Stage1-vs-Stage3 |
5.884600E-01 |
| Stage1-vs-Stage4 |
1.171560E-01 |
| Stage2-vs-Stage3 |
5.251200E-01 |
| Stage2-vs-Stage4 |
8.626800E-01 |
| Stage3-vs-Stage4 |
5.845700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.162370E-02 |
| Normal-vs-AfricanAmerican |
9.100200E-02 |
| Normal-vs-Asian |
2.560600E-01 |
| Caucasian-vs-AfricanAmerican |
7.734800E-01 |
| Caucasian-vs-Asian |
2.546400E-01 |
| AfricanAmerican-vs-Asian |
2.945600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.750300E-02 |
| Normal-vs-Female |
4.263700E-02 |
| Male-vs-Female |
9.797800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.520200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.128450E-01 |
| Normal-vs-Age(61-80Yrs) |
1.035830E-01 |
| Normal-vs-Age(81-100Yrs) |
6.026200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.182400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.836600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.830400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.514600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.966200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.658970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.430600E-01 |
| Classical-VS-Follicular |
1.00599999997009E-07 |
| Classical-VS-Other |
4.982400E-01 |
| Classical-VS-Normal |
7.001800E-04 |
| Tall-VS-Follicular |
1.999100E-03 |
| Tall-VS-Other |
4.593800E-01 |
| Tall-VS-Normal |
4.022200E-02 |
| Follicular-VS-Other |
3.210200E-01 |
| Follicular-VS-Normal |
6.185500E-02 |
| Other-VS-Normal |
7.299200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.526000E-01 |
| Normal-vs-N1 |
8.419200E-01 |
| N0-vs-N1 |
3.644000E-01 |
|
|
